制造关闭稳定性整合蛋白抑制剂的一般化学原理
Fu-Yang Lin1, Jing Li1, Yonghua Xie2
1Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
小分子整合蛋白抑制剂可以通过稳定活性结构而失败. 一个新发现的化学特征,一个极性原子,可以稳定不活跃的整合蛋白形状,提供一种新的药物设计策略.
科学领域:
- 生物化学
- 药理学
- 结构生物学
背景情况:
- 综合素是关键的药物点,已获得批准的治疗方法.
- 之前的整合素小分子抑制剂 (αIIbβ3,α4β1) 在慢性疾病的晚期试验中失败.
- 部分激应,稳定高亲和整体状态,是这些故障的潜在原因.
研究的目的:
- 研究为什么某些小分子整合蛋白抑制剂在临床试验中失败.
- 确定整合素抑制的基础结构机制.
- 发现新的药物设计原则,以开发有效的整合素抗剂.
主要方法:
- 生物化学测试以评估整合素构成.
- 对结合素结合的小分子抑制剂的结构分析.
- 研究结构与活性关系,以确定主要的化学特征.
主要成果:
- 发现小分子抑制剂的整合蛋白αIIbβ3和α4β1稳定了高亲和度的扩展开放形状.
- 在αIIbβ3抗体中发现了一种新化学特征 (极性原子),可以稳定曲折闭合的低亲和度构造.
- 这种稳定涉及金属离子依赖粘附位 (MIDAS) 的水分子,防止过渡到开放状态.
结论:
- 通过稳定活性构造的部分激动作用导致某些整合蛋白抑制剂的失效.
- 一个简单的化学特征,一个极性,可以被利用来设计稳定不活性整合素构成的抑制剂.
- 这种药物设计原理在整合蛋白家族中具有广泛的适用性,正如α4β1整合蛋白所示.
更多相关视频
09:45Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Enzyme Inhibition
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
